|
|
|
|||||||
|
|||||||||
J. Biol. Chem., Vol. 277, Issue 51, 49799-49807, December 20, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Damage to the optic nerve in mammals induces
retrograde degeneration and apoptosis of the retinal ganglion cell
(RGC) bodies. The mechanisms that mediate the response of the neuronal
cells to the axonal injury are still unknown. We have previously
shown that semaphorins, axon guidance molecules with repulsive
cues, are capable of mediating apoptosis in cultured neuronal cells (Shirvan, A., Ziv, I., Fleminger, G., Shina, R., He, Z., Brudo, I.,
Melamed, E., and Brazilai, A. (1999) J. Neurochem. 73, 961-971). In this study, we examined the involvement of semaphorins in
an in vivo experimental animal model of complete axotomy of
the rat optic nerve. We demonstrate that a marked induction of type III semaphorin proteins takes place in ipsilateral retinas at early stages
following axotomy, well before any morphological signs of RGC apoptosis
can be detected. Time course analysis revealed that a peak of
expression occurred after 2-3 days and then declined. A small
conserved peptide derived from semaphorin 3A that was previously shown
to induce neuronal death in culture was capable of inducing RGC loss
upon its intravitreous injection into the rat eye. Moreover, we
demonstrate a marked inhibition of RGC loss when axotomized eyes were
co-treated by intravitreous injection of function-blocking antibodies
against the semaphorin 3A-derived peptide. Marked neuronal protection
from degeneration was also observed when the antibodies were applied
24 h post-injury. We therefore suggest that semaphorins are key
proteins that modulate the cell fate of axotomized RGC. Neutralization
of the semaphorin repulsive function may serve as a promising new
approach for treatment of traumatic injury in the adult mammalian
central nervous system or of ophthalmologic diseases such as glaucoma
and ischemic optic neuropathy that induce apoptotic RGC death.
Anti-semaphorin 3A Antibodies Rescue Retinal Ganglion
Cells from Cell Death following Optic Nerve Axotomy*
§,
,,,,, and Department of Neurology and the Felsenstein
Medical Research Center, Rabin Medical Center, Beilinson Campus, and
the Sackler School of Medicine, Petach Tiqva 49100 and the
¶ Department of Neurobiochemistry, George S. Wise Faculty of Life
Sciences, the Department of Cell Research and Immunology, and
the ** Sam Rothberg Glaucoma Center, Goldschleger Eye
Research Institute, Tel Aviv University, Ramat Aviv,
Tel Aviv 69978, Israel
*
This work was supported in part by the National Parkinson
Foundation, by the Claire and Amedee Martier Institute for the Study of
Visual Disorders and Blindness, Tel Aviv University, and by the Israeli
Ministry of Health (to A. B.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence may be addressed. Tel.: 972-3-640-9782;
Fax: 972-3-640-7643; E-mail: barzilai@post.tau.ac.il.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Moretti, A. Procopio, R. Lazzarini, M. R. Rippo, R. Testa, M. Marra, L. Tamagnone, and A. Catalano Semaphorin3A signaling controls Fas (CD95)-mediated apoptosis by promoting Fas translocation into lipid rafts Blood, February 15, 2008; 111(4): 2290 - 2299. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. X. Jiang, M. Sheldrick, A. Desbois, J. Slinn, and S. T. Hou Neuropilin-1 Is a Direct Target of the Transcription Factor E2F1 during Cerebral Ischemia-Induced Neuronal Death In Vivo Mol. Cell. Biol., March 1, 2007; 27(5): 1696 - 1705. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. H. Majed, S. Chandran, S. P. Niclou, R. S. Nicholas, A. Wilkins, M. G. Wing, K. E. Rhodes, M. G. Spillantini, and A. Compston A Novel Role for Sema3A in Neuroprotection from Injury Mediated by Activated Microglia J. Neurosci., February 8, 2006; 26(6): 1730 - 1738. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Uchida, T. Ohshima, Y. Sasaki, H. Suzuki, S. Yanai, N. Yamashita, F. Nakamura, K. Takei, Y. Ihara, K. Mikoshiba, et al. Semaphorin3A signalling is mediated via sequential Cdk5 and GSK3{beta} phosphorylation of CRMP2: implication of common phosphorylating mechanism underlying axon guidance and Alzheimer's disease Genes Cells, February 1, 2005; 10(2): 165 - 179. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. de Winter, Q. Cui, N. Symons, J. Verhaagen, and A. R. Harvey Expression of Class-3 Semaphorins and Their Receptors in the Neonatal and Adult Rat Retina Invest. Ophthalmol. Vis. Sci., December 1, 2004; 45(12): 4554 - 4562. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Goldberg, M. E. Vargas, J. T. Wang, W. Mandemakers, S. F. Oster, D. W. Sretavan, and B. A. Barres An Oligodendrocyte Lineage-Specific Semaphorin, Sema5A, Inhibits Axon Growth by Retinal Ganglion Cells J. Neurosci., May 26, 2004; 24(21): 4989 - 4999. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kikuchi, A. Kishino, O. Konishi, K. Kumagai, N. Hosotani, I. Saji, C. Nakayama, and T. Kimura In Vitro and in Vivo Characterization of a Novel Semaphorin 3A Inhibitor, SM-216289 or Xanthofulvin J. Biol. Chem., October 31, 2003; 278(44): 42985 - 42991. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. I. Dubreuil, M. J. Winton, and L. McKerracher Rho activation patterns after spinal cord injury and the role of activated Rho in apoptosis in the central nervous system J. Cell Biol., July 21, 2003; 162(2): 233 - 243. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |